Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hines

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
BJU International|June 3, 2015
Robot-assisted intracorporeal pyramid neobladderWei Shen Tan, Ashwin Sridhar, Miles Goldstraw, et al.
The Journal of Sexual Medicine|March 6, 2016
Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated MeasuresAshwin N Sridhar, Paul J Cathcart, Tet Yap, et al.
Diabetes Technology & Therapeutics|October 25, 2002
Technologies for Metabolic Monitoring (TMM): a new research initiativeMichael Hopmeier, John F Glenn, Robert Goldstein, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
Urologic Oncology|March 13, 2016
Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomesWei Shen Tan, Ashwin Sridhar, Gidon Ellis, et al.
Cardiovascular and Interventional Radiology|November 3, 2025
Three-Month Magnetic Resonance Imaging Post-Prostate Artery Embolization Predicts 1-Year Clinical OutcomesConrad von Stempel, Lazaros Tzelves, Sukhmani Khangura, et al.
Nature Communications|February 11, 2021
Mutant-selective degradation by BRAF-targeting PROTACsShanique Alabi, Saul Jaime-Figueroa, Zhan Yao, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 10, 2009
LC/MS characterization of impurities and degradation products of a potent antitumor peptidic dimer, CU201Jennie Wang, Vidhya Krishnamoorthi, Euphemia Wang, et al.
Science Advances|March 27, 2024
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signalingZhenyi Hu, Po-Han Chen, Wenxue Li, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
BJU International|June 3, 2015
Robot-assisted intracorporeal pyramid neobladderWei Shen Tan, Ashwin Sridhar, Miles Goldstraw, et al.
The Journal of Sexual Medicine|March 6, 2016
Recovery of Baseline Erectile Function in Men Following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated MeasuresAshwin N Sridhar, Paul J Cathcart, Tet Yap, et al.
Diabetes Technology & Therapeutics|October 25, 2002
Technologies for Metabolic Monitoring (TMM): a new research initiativeMichael Hopmeier, John F Glenn, Robert Goldstein, et al.
Plos One|September 24, 2015
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation SystemLei Xu, Xueying Mao, Ahmet Imrali, et al.
Urologic Oncology|March 13, 2016
Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomesWei Shen Tan, Ashwin Sridhar, Gidon Ellis, et al.
Cardiovascular and Interventional Radiology|November 3, 2025
Three-Month Magnetic Resonance Imaging Post-Prostate Artery Embolization Predicts 1-Year Clinical OutcomesConrad von Stempel, Lazaros Tzelves, Sukhmani Khangura, et al.
Nature Communications|February 11, 2021
Mutant-selective degradation by BRAF-targeting PROTACsShanique Alabi, Saul Jaime-Figueroa, Zhan Yao, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 10, 2009
LC/MS characterization of impurities and degradation products of a potent antitumor peptidic dimer, CU201Jennie Wang, Vidhya Krishnamoorthi, Euphemia Wang, et al.
Science Advances|March 27, 2024
EGFR targeting PhosTACs as a dual inhibitory approach reveals differential downstream signalingZhenyi Hu, Po-Han Chen, Wenxue Li, et al.
ACS Chemical Biology|June 13, 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion ProteinsDennis L Buckley, Kanak Raina, Nicole Darricarrere, et al.
Pageof 10